Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 254

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis

Open access
Lagier, Jean-Christophe, Million, Matthieu, Gautret, Philippe, Colson, Philippe, Cortaredona, Sébastien, Giraud-Gatineau, Audrey, Honoré, Stéphane, Gaubert, Jean-Yves, Fournier, Pierre-Edouard, Tissot-Dupont, Hervé, Chabrière, Eric, Stein, Andreas, Deharo, Jean-Claude, Fenollar, Florence, Rolain, Jean-Marc, Obadia, Yolande, Jacquier, Alexis, La Scola, Bernard, Brouqui, Philippe, Drancourt, Michel, Parola, Philippe, Raoult, Didier, Amrane, Sophie, Aubry, Camille, Bardou, Matthieu, Berenger, Cyril, Camoin-Jau, Laurence, Cassir, Nadim, Decoster, Claire, Dhiver, Catherine, Doudier, Barbara, Edouard, Sophie, Gentile, Stéphanie, Guillon-Lorvellec, Katell, Hocquart, Marie, Levasseur, Anthony, Mailhe, Morgane, Ravaux, Isabelle, Richez, Magali, Roussel, Yanis, Seng, Piseth, Tomei, Christelle, Zandotti, Christine · 2020 · Travel Medicine and Infectious Disease

Abstract

BACKGROUND: In our institute in Marseille, France, we initiated early and massive screening for coronavirus disease 2019 (COVID-19). Hospitalization and early treatment with hydroxychloroquine and azithromycin (HCQ-AZ) was proposed for the positive cases. METHODS: We retrospectively report the clinical management of 3,737 screened patients, including 3,119 (83.5%) treated with HCQ-AZ (200 mg of oral HCQ, three times daily for ten days and 500 mg of oral AZ on day 1 followed by 250 mg daily for the next four days, respectively) for at least three days and 618 (16.5%) patients treated with other regimen ("others"). Outcomes were death, transfer to the intensive care unit (ICU), ≥10 days of hospitalization and viral shedding. RESULTS: The patients' mean age was 45 (sd 17) years, 45% were male, and the case fatality rate was 0.9%. We performed 2,065 low-dose computed tomography (CT) scans highlighting lung lesions in 592 of the 991 (59.7%) patients with minimal clinical symptoms (NEWS score = 0). A discrepancy between spontaneous dyspnoea, hypoxemia and lung lesions was observed. Clinical factors (age, comorbidities, NEWS-2 score), biological factors (lymphocytopenia; eosinopenia; decrease in blood zinc; and increase in D-dimers, lactate dehydrogenase, creatinine phosphokinase, troponin and C-reactive protein) and moderate and severe lesions detected in low-dose CT scans were associated with poor clinical outcome. Treatment with HCQ-AZ was associated with a decreased risk of transfer to ICU or death (Hazard ratio (HR) 0.18 0.11-0.27), decreased risk of hospitalization ≥10 days (odds ratios 95% CI 0.38 0.27-0.54) and shorter duration of viral shedding (time to negative PCR: HR 1.29 1.17-1.42). QTc prolongation (>60 ms) was observed in 25 patients (0.67%) leading to the cessation of treatment in 12 cases including 3 cases with QTc> 500 ms. No cases of torsade de pointe or sudden death were observed. CONCLUSION: Although this is a retrospective analysis, results suggest that early diagnosis, early isolation and early treatment of COVID-19 patients, with at least 3 days of HCQ-AZ lead to a significantly better clinical outcome and a faster viral load reduction than other treatments.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tmaid.2020.101791

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

2 retracted

Show all 37 references

Cited by

See all 254

Metadata

Authors
Lagier, J.-C., Million, M., Gautret, P., Colson, P., Cortaredona, S., Giraud-Gatineau, A., Honoré, S., Gaubert, J.-Y., Fournier, P.-E., Tissot-Dupont, H., Chabrière, E., Stein, A., Deharo, J.-C., Fenollar, F., Rolain, J.-M., Obadia, Y., Jacquier, A., La Scola, B., Brouqui, P., Drancourt, M., Parola, P., Raoult, D., Amrane, S., Aubry, C., Bardou, M., Berenger, C., Camoin-Jau, L., Cassir, N., Decoster, C., Dhiver, C., Doudier, B., Edouard, S., Gentile, S., Guillon-Lorvellec, K., Hocquart, M., Levasseur, A., Mailhe, M., Ravaux, I., Richez, M., Roussel, Y., Seng, P., Tomei, C., & Zandotti, C.
Venue
Travel Medicine and Infectious Disease
Publisher
Elsevier BV
Published
2020-07
Volume
36
Pages
101791
ISSN
1477-8939 (ISSN-L)
OpenAlex
W3037845546
Cited by
254
References
37
FWCI
7.18
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. https://app.cochat.ai/papers/10.1016/j.tmaid.2020.101791
The paper
Lagier, J.-C., Million, M., Gautret, P., Colson, P., Cortaredona, S., Giraud-Gatineau, A., Honoré, S., Gaubert, J.-Y., Fournier, P.-E., Tissot-Dupont, H., Chabrière, E., Stein, A., Deharo, J.-C., Fenollar, F., Rolain, J.-M., Obadia, Y., Jacquier, A., La Scola, B., Brouqui, P., . . . Zandotti, C. (2020). Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Medicine and Infectious Disease. https://doi.org/10.1016/j.tmaid.2020.101791

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.